BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 234 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $89,992,591 | +0.6% | 12,710,818 | 0.0% | 0.52% | +0.2% |
| Q2 2023 | $89,484,159 | -15.6% | 12,710,818 | 0.0% | 0.52% | -10.2% |
| Q1 2023 | $106,008,222 | -27.4% | 12,710,818 | 0.0% | 0.58% | -34.1% |
| Q4 2022 | $145,920,191 | -8.9% | 12,710,818 | 0.0% | 0.88% | -16.5% |
| Q3 2022 | $160,156,000 | +19.1% | 12,710,818 | 0.0% | 1.05% | +37.5% |
| Q2 2022 | $134,480,000 | -34.9% | 12,710,818 | 0.0% | 0.76% | -35.8% |
| Q1 2022 | $206,678,000 | +17.4% | 12,710,818 | 0.0% | 1.19% | +38.6% |
| Q4 2021 | $176,045,000 | -3.6% | 12,710,818 | 0.0% | 0.86% | +6.9% |
| Q3 2021 | $182,654,000 | -9.1% | 12,710,818 | 0.0% | 0.80% | -9.2% |
| Q2 2021 | $200,958,000 | +55.5% | 12,710,818 | 0.0% | 0.88% | +57.7% |
| Q1 2021 | $129,269,000 | +36.7% | 12,710,818 | +0.1% | 0.56% | +57.3% |
| Q4 2020 | $94,584,000 | +116.9% | 12,695,818 | 0.0% | 0.36% | +104.6% |
| Q3 2020 | $43,610,000 | -33.5% | 12,695,818 | -7.8% | 0.17% | -39.8% |
| Q2 2020 | $65,597,000 | +199.6% | 13,766,405 | +25.8% | 0.29% | +114.1% |
| Q1 2020 | $21,892,000 | -42.0% | 10,946,166 | 0.0% | 0.14% | -32.8% |
| Q4 2019 | $37,764,000 | +3.6% | 10,946,166 | -14.0% | 0.20% | -19.0% |
| Q3 2019 | $36,458,000 | -33.1% | 12,725,472 | -11.5% | 0.25% | -33.0% |
| Q2 2019 | $54,510,000 | -55.7% | 14,382,673 | -4.9% | 0.37% | -53.0% |
| Q1 2019 | $123,061,000 | +1.0% | 15,118,081 | +0.1% | 0.79% | -21.0% |
| Q4 2018 | $121,882,000 | +5.8% | 15,103,081 | 0.0% | 1.00% | +31.5% |
| Q3 2018 | $115,237,000 | +43.5% | 15,103,081 | +7.8% | 0.76% | +25.9% |
| Q2 2018 | $80,290,000 | +20.1% | 14,012,172 | 0.0% | 0.60% | +6.3% |
| Q1 2018 | $66,838,000 | -2.7% | 14,012,172 | +0.1% | 0.57% | -4.9% |
| Q4 2017 | $68,726,000 | -6.3% | 13,997,172 | 0.0% | 0.60% | +0.2% |
| Q3 2017 | $73,346,000 | +12.6% | 13,997,172 | +19.5% | 0.60% | +4.4% |
| Q2 2017 | $65,145,000 | -33.8% | 11,716,784 | 0.0% | 0.57% | -29.2% |
| Q1 2017 | $98,421,000 | +41.8% | 11,716,784 | +6.9% | 0.80% | +18.4% |
| Q4 2016 | $69,402,000 | +43.5% | 10,963,944 | 0.0% | 0.68% | +54.9% |
| Q3 2016 | $48,351,000 | +13.4% | 10,963,944 | -27.0% | 0.44% | -1.8% |
| Q2 2016 | $42,630,000 | +0.4% | 15,010,534 | 0.0% | 0.45% | -0.2% |
| Q1 2016 | $42,480,000 | -71.0% | 15,010,534 | +5.6% | 0.45% | -63.2% |
| Q4 2015 | $146,727,000 | -8.8% | 14,217,779 | +0.8% | 1.22% | -18.2% |
| Q3 2015 | $160,856,000 | -6.9% | 14,110,179 | +21.9% | 1.49% | -2.0% |
| Q2 2015 | $172,849,000 | +82.7% | 11,577,299 | +10.5% | 1.52% | +92.6% |
| Q1 2015 | $94,618,000 | -27.4% | 10,478,204 | -2.2% | 0.79% | -40.8% |
| Q4 2014 | $130,278,000 | +24.3% | 10,713,686 | 0.0% | 1.33% | +0.8% |
| Q3 2014 | $104,780,000 | -24.5% | 10,713,686 | -1.6% | 1.32% | -22.4% |
| Q2 2014 | $138,859,000 | +123.7% | 10,890,872 | +85.6% | 1.70% | +115.6% |
| Q1 2014 | $62,073,000 | +21.9% | 5,867,031 | -12.4% | 0.79% | +9.9% |
| Q4 2013 | $50,920,000 | +4.4% | 6,699,979 | 0.0% | 0.72% | +3.6% |
| Q3 2013 | $48,776,000 | +465.7% | 6,699,979 | +20.4% | 0.69% | +305.3% |
| Q2 2013 | $8,623,000 | – | 5,563,615 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 3,926,700 | $56,427,000 | 4.43% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,920,733 | $27,601,000 | 3.44% |
| HealthCor Management, L.P. | 3,849,470 | $55,317,000 | 2.39% |
| MPM BioImpact LLC | 704,767 | $10,128,000 | 1.57% |
| Baker Brothers Advisors | 12,710,818 | $182,654,000 | 0.80% |
| Bain Capital Public Equity Management II, LLC | 1,472,471 | $21,159,000 | 0.74% |
| Biondo Investment Advisors, LLC | 267,480 | $3,844,000 | 0.66% |
| North Star Investment Management Corp. | 442,900 | $6,364,000 | 0.52% |
| DOLIVER ADVISORS, LP | 100,000 | $1,437,000 | 0.48% |
| Lisanti Capital Growth, LLC | 219,450 | $3,153,000 | 0.46% |